Top Markets
Coin of the day
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Rang în acțiuni #28218
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Preț acțiune
$0.4
Ultima sincronizare: 2026-10-02
Capitalizare de piață
$27.18M
Schimbare (1 zi)
-14.88%
Schimbare (1 an)
8.11%
Țară
US
Tranzacționează Cell Source, Inc. (CLCS)

Categorie

Istoric al prețului acțiunii pentru Cell Source, Inc. (CLCS)
Cel mai mare preț de închidere: $0.43 pe 2026-10-01

Cel mai mic preț de închidere: $0.88 pe 2014-05-01
Istoric al prețului acțiunii pentru Cell Source, Inc. din 2014 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 57.71%
2025 -22.76%
2024 28.36%
2023 -41.25%
2022 -46.94%
2021 9.84%
2020 34.16%
2019 39.21%
2018 131.41%
2017 -37.38%
2016 -65.99%
2015 149.25%
2014 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$503.48 24.96%
US
$201.85 632.93%
US
$125.69 -7.66%
AU
$915.50 16.19%
NL
$766.03 9.30%
CH